Format

Send to

Choose Destination
Clin Pharmacol Ther. 2007 Nov;82(5):498-500.

The essential medicines list for a global patient population.

Author information

1
School of Medicine and Public Health, Faculty of Health, The University of Newcastle, New South Wales, Australia. Jane.Robertson@newcastle.edu.au

Abstract

Thirty years after its inception, the role, audience, and contents of the global Essential Medicines List (EML) are reviewed. Challenges for decision makers in applying the principles of medicine selection based on efficacy, safety, burden of disease, and cost effectiveness are discussed and illustrated with recent decisions of the Expert Committee. Areas of controversy for decision makers are highlighted, and the advocacy role of the EML for both drug procurement and development of quality-assured products is described.

PMID:
17952104
DOI:
10.1038/sj.clpt.6100392
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center